FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 07/17/2020 |
3. Issuer Name and Ticker or Trading Symbol
3D SYSTEMS CORP [ DDD ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 105,071(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Performance Based Restricted Stock | (2) | (2) | Common Stock | 10,000(2) | (2) | D | |
Performance Based Restricted Stock | (3) | (3) | Common Stock | 10,000(3) | (3) | D | |
Performance Based Stock Option (Right to Buy) | (4) | 12/01/2026 | Common Stock | 50,000(4) | $13.28 | D | |
Performance Based Stock Option (Right to Buy) | (5) | 12/01/2026 | Common Stock | 50,000(5) | $13.28 | D |
Explanation of Responses: |
1. This amount includes 62,040 shares of restricted stock ("RSAs") issued pursuant to the Issuer's 2015 Incentive Plan. Of these shares, 5,700 RSAs vest on August 15, 2020; 6,092 RSAs vest on February 15, 2021; 6,091 RSAs vest on February 15, 2021; 8,328 RSAs vest on December 13, 2020; 4,165 RSAs vest on December 13, 2021; 4,164 RSAs vest on December 13, 2022; 9,167 RSAs vest on February 15, 2021; 9,167 RSAs vest on February 15, 2022; and 9,166 RSAs vest on February 15, 2023. This amount also inlcudes 2,351 restricted stock units issued pursuant to the Issuer's 2015 Incentive Plan that vest on March 1, 2021. |
2. The Reporting Person has been awarded 10,000 shares of restricted stock under the Issuer's 2015 Incentive Plan. These shares of restricted stock vest, if at all, on the later date that is six months after the date of grant and the date that the closing price of a share of the common stock on each trading day during the immediately prior ninety consecutive calendar days is at least $30. |
3. The Reporting Person has been awarded 10,000 shares of restricted stock under the Issuer's 2015 Incentive Plan. These shares of restricted stock vest, if at all, on the later date that is six months after the date of grant and the date that the closing price of a share of the common stock on each trading day during the immediately prior ninety consecutive calendar days is at least $40. |
4. The Reporting Person has been awarded 50,000 options under the Issuer's 2015 Incentive Plan. These options to purchase the shares of common stock at an exercise price equal to the closing price of the common stock on December 1, 2016 are exercisable, if at all, on the later of the date that is six months after the date of grant and the date that the closing price of a share of the common stock on each of the trading days during the immediately prior ninety consecutive calendar days is at least $30. |
5. The Reporting Person has been awarded 50,000 options under the Issuer's 2015 Incentive Plan. These options to purchase the shares of common stock at an exercise price equal to the closing price of the common stock on December 1, 2016 are exercisable, if at all, on the later of the date that is six months after the date of grant and the date that the closing price of a share of the common stock on each of the trading days during the immediately prior ninety consecutive calendar days is at least $40. |
Remarks: |
/s/ Andrew M. Johnson, Attorney-in-Fact for Menno Ellis | 07/21/2020 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |